Cluster I, with luminal characteristics, papillary histology, FGFR3 mutations, and CDKN2A deletions, and Cluster II, also luminal but less differentiated, with p53 alterations and elevated HER2, showed similarities to the luminal A subtype of breast cancer. This evidence concerns the gene FGFR3 and breast carcinoma.